Supreme Court eases standard for proving patent definiteness — or does it?
By Andrew N Stein
Section 112, paragraph 2 of the Patent Act requires that a patent ‘conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor regards as the invention’. The Federal Circuit consistently has held that this statutory requirement is met, and a claim is not invalid as indefinite, so long as the claim is ‘amenable to construction’, and is not, as construed, ‘insolubly ambiguous’. See, for example, Datamize LLC v Plumtree Software Inc, 417 F.3d 1342, 1347 (Fed. Cir. 2005).
However, in Nautilus Inc v Biosig Inst Inc, 572 US ___ (2014), the US Supreme Court unanimously held that the Federal Circuit’s indefiniteness standard bred ‘lower court confusion’ because it ‘lack[ed] the precision §112, ¶2’ demands. Slip Op. at 11–12. Writing for the court, Justice Ruth Bader Ginsburg went so far as to say that the standard ‘can leave courts and the patent bar at sea without a reliable compass’ Id. at 13…
Click on the link below to read the rest of the DLA Piper briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from DLA Piper
News from The Lawyer
Briefings from DLA Piper
The European Court of Justice (CJEU) has handed down a landmark judgment concerning the patentability of stem cells in Europe.
A well-known British performing artist was granted permission to take his case to the Supreme Court, where he will appeal the Court of Appeal’s decision in OPO v MLA & STL.
Analysis from The Lawyer
Regulators are ramping up the pressure in the aftermath of recession, leaving firms to compete for compliance and restructuring work
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.